[Correlation of FDG-PET and MRI/CT with histopathology in primary diagnosis, lymph node staging and diagnosis of recurrency of head and neck cancer]
- PMID: 12063600
- DOI: 10.1055/s-2002-32215
[Correlation of FDG-PET and MRI/CT with histopathology in primary diagnosis, lymph node staging and diagnosis of recurrency of head and neck cancer]
Abstract
Aim: Correct staging of head and neck cancer is important for the patient's prognosis and further therapeutic strategies. Aim of the present study was to investigate the diagnostic value of FDG-PET regarding the pre-surgical diagnosis of primary tumor and cervical lymph node metastases, the diagnosis of tumour recurrence, and the localisation of unknown primary, further to compare the results to those of morphological imaging modalities (CT/MRI) and to correlate the results of both methods with histopathological findings.
Patients/methods: 115 patients (pts) (72 x primary diagnosis, 37 x recurrence, and 6 x unknown primary) underwent FDG-PET (ECAT EXACT HR+) and CT or MRI. Results were correlated with histopathological findings in terms of detection of primary and recurrent tumors as well as lymph node metastases.
Results: Regarding the pre-surgical diagnosis, sensitivity and specificity for identifying primary tumors were 85 % and 100 % for PET and 88 % and 75 % for CT/MRI, respectively. Accuracy was 86 % for PET and 87 % for CT/MRI. Sensitivity and specificity for detecting primary lymph node involvement were 71 %/86 % for PET and 74 %/57 % for CT/MRI, resulting in an accuracy of 77 % with PET and 68 % with morphological imaging. In 23 pts histopathology revealed pT1 stages with tumor diameters < 12 mm. In 8 pts CT/MRI and in 10 pts PET failed to identify these small primary lesions. Detecting tumor recurrence (n = 37) PET showed a higher sensitivity (83 %), specificity (76 %) and accuracy (78 %) compared to CT/MRI (sensitivity: 67 %; specificity: 52 %; accuracy: 57 %). In 4/6 pts with unknown primary, imaging was able to identify a primary lesion (3/4 in FDG-PET, 2/4 in CT/MRI), in 2/6 patients even in the follow-up no primary tumor was found.
Conclusions: FDG-PET provides only minor additional information to morphological imaging concerning diagnosis of primary tumors. At a similar level of sensitivity, however, it seems to be more specific regarding the lymph node involvement. PET seems to be superior to CT/MRI in detecting tumor recurrence as well as occult primary tumors in pts with known cervical lymph node metastases.
Similar articles
-
18F-FDG PET and CT/MRI in oral cavity squamous cell carcinoma: a prospective study of 124 patients with histologic correlation.J Nucl Med. 2005 Jul;46(7):1136-43. J Nucl Med. 2005. PMID: 16000282
-
A prospective diagnostic accuracy study of 18F-fluorodeoxyglucose positron emission tomography/computed tomography, multidetector row computed tomography, and magnetic resonance imaging in primary diagnosis and staging of pancreatic cancer.Ann Surg. 2009 Dec;250(6):957-63. doi: 10.1097/SLA.0b013e3181b2fafa. Ann Surg. 2009. PMID: 19687736
-
18F-FDG PET/CT for detecting nodal metastases in patients with oral cancer staged N0 by clinical examination and CT/MRI.J Nucl Med. 2006 May;47(5):755-62. J Nucl Med. 2006. PMID: 16644744 Clinical Trial.
-
What is the best way to diagnose and stage malignant pleural mesothelioma?Interact Cardiovasc Thorac Surg. 2011 Feb;12(2):254-9. doi: 10.1510/icvts.2010.255893. Epub 2010 Nov 1. Interact Cardiovasc Thorac Surg. 2011. PMID: 21044972 Review.
-
[The value of MRI in staging gynecologic tumors].Aktuelle Radiol. 1996 Mar;6(2):63-8. Aktuelle Radiol. 1996. PMID: 8679726 Review. German.
Cited by
-
Oral cavity squamous cell carcinoma and the clinically n0 neck: the past, present, and future of sentinel lymph node biopsy.Curr Oncol Rep. 2010 Mar;12(2):129-35. doi: 10.1007/s11912-010-0090-7. Curr Oncol Rep. 2010. PMID: 20425598 Free PMC article. Review.
-
Nuclear medicine imaging for the assessment of primary and recurrent head and neck carcinoma using routinely available tracers.Eur J Nucl Med Mol Imaging. 2003 Dec;30(12):1689-700. doi: 10.1007/s00259-003-1345-4. Epub 2003 Oct 22. Eur J Nucl Med Mol Imaging. 2003. PMID: 14574516 Review.
-
The Value of Surveillance Imaging of Oral Squamous Cell Carcinoma.Cancers (Basel). 2024 Jan 1;16(1):207. doi: 10.3390/cancers16010207. Cancers (Basel). 2024. PMID: 38201635 Free PMC article.
-
[PET/CT in radiotherapy].Radiologe. 2004 Nov;44(11):1096-104. doi: 10.1007/s00117-004-1124-7. Radiologe. 2004. PMID: 15517138 German.
-
Functional imaging in head and neck squamous cell carcinoma: correlation of PET/CT and diffusion-weighted imaging at 3 Tesla.Eur J Nucl Med Mol Imaging. 2011 Jun;38(6):1009-19. doi: 10.1007/s00259-010-1718-4. Epub 2011 Apr 5. Eur J Nucl Med Mol Imaging. 2011. PMID: 21465255
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical